top of page
Search Results

568 items found for "GPCR Therapeutics"

  • Logo Contest | Dr. GPCR Ecosystem

    Artist-scientists must be registered to attend the adhesion GPCR workshop 2024 in Mexico City. Workshop 2024 + One Year Free Premium Membership Select Adhesion GPCR Workshop 2024 One Year Dr. GPCR Premium Membership Adhesion Workshop for Students $ 200 200$ Every year Adhesion GPCR Workshop 2024 + One Year Free Premium Membership Select Adhesion GPCR Workshop 2024 One Year Dr. GPCR Premium Membership Sponsor this event

  • Prediction of survival and immunotherapy response by the combined classifier of G protein-coupled receptors and tumor microenvironment in melanoma

    < GPCR News < GPCRs in Oncology and Immunology Prediction of survival and immunotherapy response by the mediator in the advancement of OSCC, offering a potential avenue for the development of innovative therapeutic News Coming soon Become a Contributor Classified GPCR News Call for GPCR papers GPCR Industry News Adhesion GPCRs GPCR Events, Meetings, and Webinars Reviews, GPCRs, and more GPCR Binders, Drugs, and more Methods & Updates in GPCR Research GPCRs in Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs

  • From odor to oncology: non-canonical odorant receptors in cancer

    These findings shed light on the potential of non-canonical odorant receptors as therapeutic targets these chemoreceptors and various types of cancer, potentially paving the way for innovative odor-based therapeutics Ultimately, this review discusses the potential development of novel therapeutic strategies targeting a Contributor Classified GPCR News Call for GPCR papers GPCR Industry News Adhesion GPCRs GPCR Events GPCR Research GPCRs in Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs in Oncology and

  • Summit | Dr. GPCR Ecosystem

    GPCR Summit We live in a new world, and we think it's an opportunity to try new things and use current technologies to help us connect and spread scientific advances in the GPCR field. Our goal is to allow everyone in the GPCR community to get access to the talks through the entire length

  • Dr. GPCR Podcast

    GPCR Podcast Listen and subscribe where you get your podcasts

  • Ep 151 with Dr. GPCR Board

    GPCR VideoCast << Back to VideoCast list Dr. GPCR Board About Dr. Yamina Berchiche "Dr. Yamina A. (GPCRs) that control virtually everything in the body as drug targets. GPCR is to accelerate GPCR drug discovery by sharing the latest research and technology advances in the GPCR podcast. Dr. GPCR About Dr.

  • Dr. GPCR Summit 2021 Live Talks

    GPCR Summit Partners - Click to Explore - Summit 2021 Full Schedule & Details Dr. GPCR Summit 2021 Live Talk Schedule GPCRdb Resources Dr. David Gloriam, Dr. GPCR Summit Dr. Robert Lefkowitz, Dr. GPCR Summit Partners - Click to Explore - Tags Dr. GPCR Summit Dr. GPCR Summit 2021 Dr. GPCR Summit 2021 Pre-Recorded Talks Dr. GPCR Summit 2021Live Talks

  • Adhesion | Dr. GPCR Ecosystem

    Register Welcome to the Adhesion GPCR Workshop 2024 , hosted in the vibrant heart of Mexico City at the Workshop 2024 + One Year Free Premium Membership Select Adhesion GPCR Workshop 2024 One Year Dr. GPCR Premium Membership Adhesion Workshop for Students $ 200 200$ Every year Adhesion GPCR Workshop 2024 + One Year Free Premium Membership Select Adhesion GPCR Workshop 2024 One Year Dr. GPCR Premium Membership Sponsor this event Learn more about the Adhesion GPCR workshop 2024 Up Abstract

  • Advanced data analysis for GPCR pharmacology

    Advanced data analysis for GPCR pharmacology Price [object Object] Duration Course duration: 4 Weeks Enroll < Back About the Course Main objectives: Learning how to perform advanced GPCR pharmacology data analysis in support of drug discovery and GPCR research, shown with GraphPad Prism. Understanding the pharmacology data analysis framework we use for GPCRs. Appreciating the practical realities, limitations, and tradeoffs of GPCR data analysis.

  • Explore / Organizations | Dr. GPCR Ecosystem

    GPCR Strategic Partner Request Your Quote How Organizations can benefit from Dr. GPCR Ecosystem? company page today and share who you are with the Ecosystem Discover Product Listings Add your company's GPCR the Ecosystem know and meet your customers at these events Discover Job Listings Looking to hire a GPCR where your company is going to events Discover Product Listings Get your products in front of your GPCR GPCR Ecosystem.

  • A GPCR checkpoint drives CD8+ T cell dysfunction and immunotherapy failure in mice

    < GPCR News < GPCRs in Oncology and Immunology A GPCR checkpoint drives CD8+ T cell dysfunction and immunotherapy News Coming soon Become a Contributor Classified GPCR News Call for GPCR papers GPCR Industry News Adhesion GPCRs GPCR Events, Meetings, and Webinars Reviews, GPCRs, and more GPCR Binders, Drugs, and more Methods & Updates in GPCR Research GPCRs in Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs GPCR News and get weekly notifications about the GPCR field Share < Previous Next >

  • Ep 122 with Dr. Nicolas Gilles

    GPCR Podcast << Back to podcast list Dr. GPCR Board About Dr. Nicolas Gilles "Dr. He is pioneering the investigation of animal toxins acting on GPCRs, the largest therapeutic target class His strongest expertise lies in therapeutic target identification and all the steps from venom manipulations pharmacological properties of these new ligands are deemed exceptional, a lead optimization is realized and its therapeutic GPCR Listen and subscribe where you get your podcasts << Previous Podcast Episode Next Podcast Episode

  • Ep 81 with Dr. Christel Menet

    GPCR Podcast << Back to podcast list Dr. GPCR Board About Dr. I then started my career at Evotec before moving to Domain Therapeutics (called Faust pharmaceutical chemistry. 6 years ago I decided to take on a new challenge by taking the position of CSO at Confo Therapeutics was the 6th employee and today we are more than 60 :) I have fun every day, and I love working with GPCRs Christel Menet on the web Hyphen Projects GPCRS Drug Discovery Confo Therapeutics LinkedIn Dr.

  • Home | Dr. GPCR Ecosystem

    GPCR Ecosystem We dream of a world where the vast majority of us lead a fulfilling and healthy life. Join Us Today We aspire to provide opportunities to connect, grow, and thrive as a great GPCR Community

  • Newsletter Sign Up | Dr. GPCR Ecosystem

    GPCR Newsletter We want to bring you closer to what's happening in the GPCR world and yet want to avoid up with the idea of a monthly newsletter in which we've curated the major advances in understanding GPCR

  • G protein-coupled estrogen receptor (GPER)/GPR30 forms a complex with the β1-adrenergic receptor, a membrane-associated guanylate kinase (MAGUK) scaffold protein, and protein kinase A anchoring protein (AKAP) 5 in MCF7 breast cancer cells

    < GPCR News < GPCRs in Oncology and Immunology G protein-coupled estrogen receptor (GPER)/GPR30 forms Coming soon Become a Contributor Classified GPCR News Call for GPCR papers GPCR Industry News Adhesion GPCRs GPCR Events, Meetings, and Webinars Reviews, GPCRs, and more GPCR Binders, Drugs, and more Methods & Updates in GPCR Research GPCRs in Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs GPCR News and get weekly notifications about the GPCR field Share < Previous Next >

  • Opposite Effects of Src Family Kinases on YAP and ERK Activation in Pancreatic Cancer Cells: Implications for Targeted Therapy

    < GPCR News < GPCRs in Oncology and Immunology Opposite Effects of Src Family Kinases on YAP and ERK As therapeutic options are limited, novel targets, and agents for therapeutic intervention are urgently News Coming soon Become a Contributor Classified GPCR News Call for GPCR papers GPCR Industry News Adhesion GPCRs GPCR Events, Meetings, and Webinars Reviews, GPCRs, and more GPCR Binders, Drugs, and more Methods & Updates in GPCR Research GPCRs in Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs

  • GPR68-ATF4 signaling is a novel prosurvival pathway in glioblastoma activated by acidic extracellular microenvironment

    < GPCR News < GPCRs in Oncology and Immunology GPR68-ATF4 signaling is a novel prosurvival pathway in These findings provide a promising therapeutic approach to selectively induce ferroptosis in glioblastoma News Coming soon Become a Contributor Classified GPCR News Call for GPCR papers GPCR Industry News Adhesion GPCRs GPCR Events, Meetings, and Webinars Reviews, GPCRs, and more GPCR Binders, Drugs, and more Methods & Updates in GPCR Research GPCRs in Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs

  • Ep 81 with Dr. Christel Menet

    GPCR VideoCast << Back to VideoCast list Dr. Christel Menet About Dr. I then started my career at Evotec before moving to Domain Therapeutics (called Faust pharmaceutical chemistry. 6 years ago I decided to take on a new challenge by taking the position of CSO at Confo Therapeutics Christel Menet on the web Hyphen Projects GPCRS Drug Discovery Confo Therapeutics LinkedIn Dr. GPCR Ecosystem Listen and subscribe where you get your podcasts Tags ​ << Previous VideoCast Episode

  • Home#2 | Dr. GPCR Ecosystem

    GPCR Ecosystem We dream of a world where the vast majority of us lead a fulfilling and healthy life. Join Us Today We aspire to provide opportunities to connect, grow, and thrive as a great GPCR Community

  • Clinical, pathophysiologic, genetic and therapeutic progress in Primary Bilateral Macronodular Adrenal Hyperplasia

    < GPCR News < GPCRs in Oncology and Immunology Clinical, pathophysiologic, genetic and therapeutic progress Source Contribute to the GPCR News Coming soon Become a Contributor Classified GPCR News Call for GPCR papers GPCR Industry News Adhesion GPCRs GPCR Events, Meetings, and Webinars Reviews, GPCRs, and more GPCR Binders, Drugs, and more Methods & Updates in GPCR Research GPCRs in Neuroscience GPCRs in Cardiology GPCR News and get weekly notifications about the GPCR field Share < Previous Next >

  • Ep 37 with Dr. Samuel Hoare

    GPCR Podcast << Back to podcast list Dr. GPCR Board About Dr. company supporting pharmaceutical, life science, and academic scientists in the development of new therapeutics analysis of drug action and is known for applying binding kinetics to the development of effective therapeutics , particularly GPCR antagonists. GPCR Member ResearchGate Dr.

  • Itaconate in host inflammation and defense

    < GPCR News < GPCRs in Oncology and Immunology Itaconate in host inflammation and defense Published date regulation, discuss its target proteins and mechanisms, and conjecture a rationale for developing ITA-based therapeutics News Coming soon Become a Contributor Classified GPCR News Call for GPCR papers GPCR Industry News Adhesion GPCRs GPCR Events, Meetings, and Webinars Reviews, GPCRs, and more GPCR Binders, Drugs, and more Methods & Updates in GPCR Research GPCRs in Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs

  • Ep 122 with Dr. Nicolas Gilles

    GPCR VideoCast << Back to VideoCast list Dr. Nicolas Gilles About Dr. Nicolas Gilles "Dr. He is pioneering the investigation of animal toxins acting on GPCRs, the largest therapeutic target class His strongest expertise lies in therapeutic target identification and all the steps from venom manipulations pharmacological properties of these new ligands are deemed exceptional, a lead optimization is realized and its therapeutic GPCR Listen and subscribe where you get your podcasts Tags ​ << Previous VideoCast Episode Next VideoCast

  • The GPCR-Gαs-PKA signaling axis promotes T cell dysfunction and cancer immunotherapy failure

    < GPCR News < GPCRs in Oncology and Immunology The GPCR-Gαs-PKA signaling axis promotes T cell dysfunction Source Contribute to the GPCR News Coming soon Become a Contributor Classified GPCR News Call for GPCR papers GPCR Industry News Adhesion GPCRs GPCR Events, Meetings, and Webinars Reviews, GPCRs, and more GPCR Binders, Drugs, and more Methods & Updates in GPCR Research GPCRs in Neuroscience GPCRs in Cardiology GPCR News and get weekly notifications about the GPCR field Share < Previous Next >

  • G Proteins and GPCRs in Cancer: Novel Precision Targeted and Immunotherapies

    Retreat 2023 About Program Registration Logo Contest Committee Sponsors GPCR Retreat Program < Back to schedule G Proteins and GPCRs in Cancer: Novel Precision Targeted and Immunotherapies Date & Time Friday His research team has pioneered the study of G proteins and G protein coupled receptors (GPCRs) in human GPCR Previous Event Next Event Great Lakes GPCR Retreat and Club des Récepteurs à Sept Domaines Transmembranaires 22nd GPCR Retreat Sponsored by

  • Ep 109 with Dr. Katarina Nemec

    GPCR Podcast << Back to podcast list Dr. GPCR Board About Dr. I aim to discover new therapeutic approaches, and druggable molecules or refine canonical drug targets while performing various cell-based experiments to understand the binding, activation, and signaling of therapeutically relevant GPCRs. GPCR Listen and subscribe where you get your podcasts << Previous Podcast Episode Next Podcast Episode

  • Ep 37 with Dr. Samuel Hoare

    company supporting pharmaceutical, life science, and academic scientists in the development of new therapeutics analysis of drug action and is known for applying binding kinetics to the development of effective therapeutics , particularly GPCR antagonists. of GPCR function to better target receptors. GPCR Member ResearchGate Dr.

bottom of page